VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
HCA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
HCAHCA Healthcare, Inc.
$404.68$87.6B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHCABalance Sheet

HCA Healthcare, Inc. (HCA) Balance Sheet

30Y historyFree accessUpdated daily

Total debt rose to $48.8B (up from $42.1B in 2024Q1) and equity turned more negative to -$6.6B, pushing debt-to-assets to roughly 81% and current ratio down to 0.78, indicating a highly leveraged and thinly liquid balance sheet.

HCA Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets14.96B13.56B16.41B14.93B13.64B13.54B12.33B11.2B10.21B9.98B9.09B9.23B8.93B8.04B7.76B7.23B6.92B6.58B6.3B6.21B6.08B5.21B4.68B4.82B4.5B4.14B4.45B3.6B3.86B4.42B4.41B
Cash & Short-Term Investments1.01B1.04B2.02B935M908M1.45B1.79B621M502M732M646M741M566M414M705M373M411M312M465M393M634M336M258M115M161M85M314M190M297M110M113M
Cash Only1.01B1.04B1.93B935M908M1.45B1.79B621M502M732M646M741M566M414M705M373M411M312M465M393M634M336M129M115M161M85M314M190M297M110M113M
Short-Term Investments0088M0000000000000000000000000000
Accounts Receivable12.28B10.87B10.75B9.96B8.89B8.1B7.05B7.38B6.79B6.5B5.83B5.89B5.69B5.21B4.67B4.53B3.83B3.69B3.78B3.9B3.71B3.33B3.08B3.1B2.79B2.51B2.41B2.05B2.25B3.05B2.84B
Days Sales Outstanding52.5252.4755.5855.9553.8850.2949.9452.4753.0954.4151.2554.1756.355.6151.6550.945.5844.8448.6352.9353.0849.7347.8851.851.5851.0952.7244.9443.8659.2352.1
Inventory1.66B1.65B1.74B2.02B2.07B1.99B2.02B1.85B1.73B1.57B1.5B1.44B1.28B1.18B1.09B1.05B897M802M737M710M669M616M577M520M462M423M396M383M434M452M441M
Days Inventory Outstanding10.9913.6315.1318.7320.3719.9988.3279.5881.8578.4879.1379.1374.5572.0869.3474.286660.1358.2358.9656.554.4953.99-------21.35
Other Current Assets001.9B2.01B1.78B2.01B1.46B1.35B1.19B1.17B1.11B1.16B1.39B1.24B1.3B1.27B1.78B1.77B1.32B1.21B1.07B931M1.14B1.09B1.09B1.12B1.33B973M887M807M806M
Total Non-Current Assets45.58B47.16B43.1B41.28B38.8B37.2B35.16B33.86B28.99B26.62B24.67B23.51B22.27B20.79B20.31B19.66B16.93B17.55B17.98B17.82B17.6B17.01B16.78B16.24B14.24B13.59B13.12B13.29B15.57B17.58B16.86B
Property, Plant & Equipment34.1B31.14B31.55B29.92B27.64B26.18B25.22B24.55B19.76B17.89B16.35B15.01B14.36B13.62B13.19B12.83B11.35B11.43B11.53B11.44B11.67B11.38B11.4B11.06B9.72B8.92B8.48B8.49B9.45B10.23B10.4B
Fixed Asset Turnover2.37x2.43x2.24x2.17x2.18x2.24x2.04x2.09x2.36x2.44x2.54x2.64x2.57x2.51x2.50x2.53x2.70x2.63x2.46x2.35x2.18x2.15x2.06x1.97x2.03x2.01x1.97x1.96x1.98x1.84x1.91x
Goodwill009.77B9.61B9.29B9.14B8.21B7.94B7.61B7.04B6.33B6.34B6.02B00002.58B2.58B2.63B2.6B2.63B2.54B2.48B1.99B2.51B00000
Intangible Assets10.66B10.29B323M339M359M403M369M330M342M359M374M393M399M5.9B5.54B5.25B2.69B0000000002.41B2.05B2.25B3.05B2.84B
Long-Term Investments3.67B633M1.23B1.23B1.2B886M810M564M594M617M542M610M659M569M619M649M1.51B2.02B2.26B2.36B2.56B2.76B2.53B2.32B2.03B2.13B2.15B2.11B2.89B2.75B2.41B
Other Non-Current Assets05.09B230M184M298M598M546M480M690M710M1.07B1.16B620M703M969M931M1.38B1.53B1.61B1.39B762M244M313M378M487M486M330M368M318M1.08B550M
Total Assets60.53B60.72B59.51B56.21B52.44B50.74B47.49B45.06B39.21B36.59B33.76B32.74B31.2B28.83B28.07B26.9B23.85B24.13B24.28B24.02B23.68B22.23B21.46B21.06B18.74B17.73B17.57B16.89B19.43B22B21.27B
Asset Turnover1.29x1.25x1.19x1.16x1.15x1.16x1.09x1.14x1.19x1.19x1.23x1.21x1.18x1.19x1.18x1.21x1.29x1.25x1.17x1.12x1.08x1.10x1.09x1.04x1.05x1.01x0.95x0.99x0.96x0.86x0.94x
Asset Growth %6.95%2.03%5.87%7.2%3.34%6.85%5.4%14.92%7.14%8.4%3.1%4.95%8.21%2.69%4.38%12.77%-1.16%-0.61%1.06%1.48%6.52%3.54%1.91%12.39%5.7%0.92%4.04%-13.09%-11.69%3.43%6.94%
Total Current Liabilities19.14B16.35B15.18B12.65B9.9B9.58B8.7B7.76B7.57B6.16B5.83B5.52B5.48B5.7B6.17B5.55B4.27B4.31B3.91B3.85B3.58B3.9B3.17B3.17B3.74B3.18B4.14B3.33B3.56B2.77B2.95B
Accounts Payable4.75B4.66B4.28B4.23B4.24B4.11B3.54B2.9B2.58B2.61B2.32B2.17B2.04B1.8B1.77B1.6B1.54B1.46B1.37B1.37B1.42B1.48B855M877M809M755M693M657M784M929M790M
Days Payables Outstanding30.6438.4537.2339.2341.7541.38154.17125.02121.78130.01122.04119.32118.62110.23112.88112.55113.08109.47108.24113.78119.5131.2880-------38.24
Short-Term Debt8.1B6.74B4.7B2.42B370M237M209M145M788M200M216M233M338M786M1.44B1.41B592M846M404M308M293M586M486M665M446M807M1.12B1.16B1.07B132M201M
Deferred Revenue (Current)0000000000000000000000000000000
Other Current Liabilities3.9B2.42B910M867M794M549M547M528M459M67M0000000000000000000046M
Current Ratio0.78x0.83x1.08x1.18x1.38x1.41x1.42x1.44x1.35x1.62x1.56x1.67x1.63x1.41x1.26x1.30x1.62x1.52x1.61x1.61x1.70x1.34x1.48x1.52x1.20x1.30x1.08x1.08x1.09x1.60x1.50x
Quick Ratio0.69x0.73x0.97x1.02x1.17x1.21x1.18x1.20x1.12x1.36x1.30x1.41x1.40x1.20x1.08x1.11x1.41x1.34x1.42x1.43x1.51x1.18x1.29x1.36x1.08x1.17x0.98x0.96x0.96x1.43x1.35x
Cash Conversion Cycle32.8627.6533.4835.4532.4928.9-15.917.0213.162.878.3513.9812.2317.468.1112.63-1.5-4.49-1.38-1.88-9.92-27.0521.87-------35.21
Total Non-Current Liabilities44.53B47.14B43.78B42.5B42.61B39.67B35.89B37.87B34.56B35.43B33.56B33.27B32.22B30.06B30.24B28.36B30.38B27.8B29.63B29.78B30.57B12.64B13.07B11.01B8.69B9.22B8.45B7.17B7.52B11.14B8.88B
Long-Term Debt38.87B41.6B38.33B37.17B37.13B33.77B30.8B33.58B32.03B32.86B31.16B30.25B29.09B27.59B27.5B25.64B27.63B24.82B26.59B27B28.11B9.89B10.04B8.04B6.5B6.55B5.63B5.28B5.68B9.28B6.78B
Capital Lease Obligations7.32B1.85B1.86B1.9B2.33B2.33B1.67B1.5B000000000000-125M0000000000
Deferred Tax Liabilities0000000000000001.72B1.61B1.77B1.78B1.38B1.02B1.41B1.75B1.65B999M000002.1B
Other Non-Current Liabilities3.85B3.69B3.58B3.42B3.14B3.57B3.43B2.79B2.52B2.57B2.4B3.02B3.13B2.47B2.75B2.71B2.6B2.97B2.89B2.61B1.31B1.34B1.28B1.31B1.19B2.67B2.82B1.89B1.84B1.87B0
Total Liabilities63.67B63.49B58.96B55.15B52.51B49.25B44.6B45.62B42.13B41.59B39.39B38.79B37.7B35.76B36.42B33.91B34.65B32.11B33.54B33.63B34.14B16.53B16.25B14.17B12.43B12.4B12.59B10.51B11.08B13.92B11.83B
Total Debt48.78B50.2B45.24B41.86B40.2B36.73B33.06B35.57B32.82B33.06B31.38B30.49B29.43B28.38B28.93B27.05B28.23B25.67B26.99B27.31B28.41B10.47B10.53B8.71B6.94B7.36B6.75B6.44B6.75B9.41B6.98B
Net Debt47.76B49.16B43.3B40.92B39.29B35.27B31.26B34.95B32.32B32.33B30.73B29.75B28.86B27.96B28.23B26.68B27.81B25.36B26.52B26.91B27.77B10.14B10.27B8.59B6.78B7.28B6.44B6.25B6.46B9.3B6.87B
Debt / Equity-15.52x-81.51x39.49x-24.66x11.43x--------------1.84x2.02x1.26x1.10x1.38x1.36x1.01x0.81x1.16x0.74x
Debt / EBITDA3.10x3.24x3.26x3.29x3.34x2.93x3.31x3.62x3.68x4.04x3.84x3.87x3.98x4.34x4.45x4.66x5.05x4.91x6.20x6.24x6.72x2.45x2.66x2.23x2.27x2.25x0.38x0.37x0.37x3.91x1.72x
Net Debt / EBITDA3.03x3.17x3.12x3.22x3.27x2.82x3.13x3.56x3.62x3.95x3.76x3.78x3.91x4.27x4.35x4.60x4.98x4.85x6.10x6.15x6.57x2.37x2.59x2.20x2.22x2.22x0.37x0.36x0.36x3.86x1.69x
Interest Coverage5.25x5.37x5.14x4.98x5.94x7.46x4.50x3.84x4.02x3.64x4.08x3.65x3.24x2.79x2.80x3.30x2.06x2.43x1.58x1.54x2.74x4.28x4.50x--------
Total Equity-3.14B-2.77B555M1.06B-73M1.49B2.89B-565M-2.92B-5B-5.63B-6.05B-6.5B-6.93B-8.34B-7.01B-10.79B-7.98B-9.26B-9.6B-10.47B5.69B5.22B6.89B6.31B5.33B4.98B6.38B8.35B8.09B9.45B
Equity Growth %-1707.67%-599.28%-47.64%1552.05%-104.9%-48.51%611.86%80.64%41.58%11.33%6.83%6.96%6.21%16.94%-18.92%35.02%-35.3%13.84%3.54%8.28%-283.92%9.11%-24.29%9.12%18.55%6.99%-21.99%-23.56%3.22%-14.39%20.3%
Book Value per Share-14.10-12.012.123.83-0.254.538.37-1.62-8.21-13.42-14.23-14.17-14.43-15.00-18.16-14.14-24.68-22.88-26.55-27.53-25.5212.7210.7813.5012.059.928.989.5712.9412.2013.93
Total Shareholders' Equity-6.58B-6.03B-2.5B-1.77B-2.77B-933M572M-2.81B-4.95B-6.81B-7.3B-7.6B-7.89B-8.27B-9.66B-8.26B-11.93B-8.99B-10.26B-10.54B-11.37B4.86B4.41B6.21B5.7B4.76B4.41B5.62B7.58B7.25B8.61B
Common Stock2M2M3M3M3M3M3M3M3M4M4M4M4M4M4M4M4M1M1M1M1M4M4M5M5M5M5M6M6M6M7M
Retained Earnings-6.25B-5.72B-2.12B-1.35B-2.28B-532M777M-2.35B-4.57B-6.53B-6.97B-7.34B-7.58B-9.4B-10.96B-9.42B-11.89B-8.76B-9.82B-10.48B-11.39B4.73B4.21B6.03B5.53B4.73B4.34B4.6B3.99B3.66B4.02B
Treasury Stock0000000000000000000000000000000
Accumulated OCI-327M-305M-387M-425M-490M-404M-502M-460M-381M-278M-338M-265M-323M-257M-457M-440M-428M-450M-604M-172M16M130M193M168M73M18M52M53M80M92M-5.32B
Minority Interest3.43B3.26B3.05B2.83B2.69B2.42B2.32B2.24B2.03B1.81B1.67B1.55B1.4B1.34B1.32B1.24B1.13B1.01B995M938M907M828M809M680M611M563M572M763M765M836M836M

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetStrained
Cash FlowRobust
Top Statement Risk

Negative equity and high leverage

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Leverage Creep Amidst Expansion

HCA's total debt climbed from $42.1B in 2024Q1 to $48.8B by 2026Q2, while equity turned more negative, according to recent SEC filings, indicating a balance sheet increasingly reliant on debt to fund growth.

The sequential increase in total debt, coupled with a widening negative equity position, suggests that HCA's aggressive capital deployment—likely for buybacks and capex—is outpacing retained earnings. This trend appears to be a deliberate strategy to leverage the balance sheet for shareholder returns, but it also raises the risk profile, especially if cash flows weaken. Investors should monitor whether this trajectory is sustainable given the company's high fixed costs and policy overhangs.

Debt-Fueled Growth Raises Stakes

Total debt reached $48.8B in 2026Q2, up from $42.1B a year earlier, as reported in financial statements, pushing debt-to-assets to roughly 81% and signaling a highly leveraged capital structure.

The debt-to-assets ratio, which stood at 81% in 2026Q2, is elevated compared to peers like UHS (D/E 0.74) and THC (D/E 1.47), though HCA's scale and cash generation may support this leverage. The increase in debt appears strategic, funding buybacks and expansion, but it also exposes HCA to interest rate risk and refinancing needs. Given the company's negative equity, the debt load is a critical vulnerability that could constrain financial flexibility if operating conditions deteriorate.

Asset-Heavy Model with Rising Intangibles

PP&E grew to $34.1B in 2026Q2 from $30.3B in 2024Q1, while goodwill rose to $10.7B, as per balance sheet data, underscoring HCA's capital-intensive operations and acquisition-driven growth.

The steady increase in PP&E reflects ongoing investment in facilities and equipment, consistent with HCA's cluster strategy. Goodwill, now $10.7B, represents a significant portion of total assets and carries impairment risk if market conditions or regulatory changes impair expected cash flows. The asset mix indicates a heavy fixed-cost base, which amplifies operating leverage but also makes earnings sensitive to volume fluctuations.

Negative Equity Deepens

Shareholders' equity fell to -$6.6B in 2026Q2 from -$1.6B in 2024Q1, according to the balance sheet, reflecting cumulative buybacks and losses that have eroded the equity base.

The negative equity is primarily driven by aggressive share repurchases, which have reduced the equity cushion, and retained earnings that remain negative. This structure is not uncommon for highly leveraged companies, but it means that HCA's solvency relies heavily on its ability to generate consistent cash flows. The trend suggests that management is prioritizing shareholder returns over balance sheet strength, which may be acceptable given the stable cash flows but warrants close monitoring.

Thin Liquidity Buffer

The current ratio fell to 0.78 in 2026Q2 from 1.16 in 2024Q1, with cash at $1.0B, as reported in financial statements, indicating a tightening liquidity position relative to short-term obligations.

A current ratio below 1.0 suggests that HCA may struggle to cover short-term liabilities with current assets alone, though the company's robust operating cash flow provides an ongoing source of liquidity. The decline in the current ratio is partly due to increased debt and possibly higher payables, but it also reflects a deliberate strategy to minimize cash on hand. Given the high debt load, this thin buffer could be a concern if cash flows were to dip unexpectedly.

Negative Equity Masks True Leverage

HCA's negative equity of -$6.6B in 2026Q2, as per the balance sheet, makes traditional D/E ratios meaningless, but the debt-to-assets ratio of 81% reveals a highly leveraged balance sheet.

The negative equity is a red flag that headline leverage metrics like D/E are not calculable, but it does not necessarily indicate distress given HCA's strong cash generation. However, it does mean that the company has no equity cushion to absorb losses, and any impairment or downturn could quickly erode solvency. This distortion warrants careful analysis of cash flow durability and the sustainability of the capital allocation strategy.

HCA — Frequently Asked Questions

Quick answers to the most common questions about buying HCA stock.

What are the total assets of HCA Healthcare, Inc. (HCA)?

As of 2025, HCA Healthcare, Inc. (HCA) had total assets of $60.72B including $13.56B in current assets.

How much debt does HCA Healthcare, Inc. (HCA) have?

HCA Healthcare, Inc. (HCA) carries total debt of $50.20B, offset by $1.04B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of HCA Healthcare, Inc.?

HCA Healthcare, Inc. (HCA) has total shareholders' equity (book value) of $-6027.0M ($-12.01 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is HCA Healthcare, Inc.'s current ratio and liquidity?

HCA Healthcare, Inc. (HCA) reported a current ratio of 0.83x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.